Literature DB >> 15602199

Human leukocyte antigens B8-DRB1*03 in pediatric patients with nephropathia epidemica caused by Puumala hantavirus.

Jukka Mustonen1, Niilo-Pekka Huttunen, Jukka Partanen, Maija Baer, Antti Paakkala, Olli Vapalahti, Matti Uhari.   

Abstract

In adults, HLA haplotype B8-DRB1*03 is clearly associated with a severe clinical course of nephropathia epidemica caused by Puumala hantavirus. We investigated whether the same applies in pediatric patients. This HLA haplotype was found in 20 of 39 (51%) of the patients, a significantly higher figure than in the Finnish population (19%). There were, however, no significant differences in the clinical picture between patients with and without HLA B8-DRB1*03.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15602199     DOI: 10.1097/01.inf.0000141737.45047.99

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  4 in total

1.  HLA-associated hemorrhagic fever with renal syndrome disease progression in slovenian patients.

Authors:  Misa Korva; Ana Saksida; Sabina Kunilo; Blanka Vidan Jeras; Tatjana Avsic-Zupanc
Journal:  Clin Vaccine Immunol       Date:  2011-07-20

Review 2.  T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic fever with renal syndrome.

Authors:  Masanori Terajima; Francis A Ennis
Journal:  Viruses       Date:  2011-07-06       Impact factor: 5.048

Review 3.  Hantavirus Research in Finland: Highlights and Perspectives.

Authors:  Antti Vaheri; Heikki Henttonen; Jukka Mustonen
Journal:  Viruses       Date:  2021-07-26       Impact factor: 5.048

4.  The genetic polymorphisms of HLA are strongly correlated with the disease severity after Hantaan virus infection in the Chinese Han population.

Authors:  Ying Ma; Bin Yuan; Jing Yi; Ran Zhuang; Jiuping Wang; Yun Zhang; Zhuwei Xu; Yusi Zhang; Bei Liu; Chao Wei; Chunmei Zhang; Angang Yang; Boquan Jin
Journal:  Clin Dev Immunol       Date:  2012-10-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.